Manuela Giuseppa Ingrascì, Claudia Cammarata, Sergio Siragusa, Marta Mattana, M. Napolitano
{"title":"Understanding and Managing Inherited Platelet Disorders: A Case Study of Storage Pool Disease","authors":"Manuela Giuseppa Ingrascì, Claudia Cammarata, Sergio Siragusa, Marta Mattana, M. Napolitano","doi":"10.12974/2311-8687.2024.12.05","DOIUrl":null,"url":null,"abstract":"Inherited platelet disorders, including platelet storage pool diseases (SPDs), manifest in various bleeding symptoms, with severity often categorized based on their effects on either the surface receptors or internal structures of platelets [1]. This rare condition, characterized by defects in platelet granules, exhibits broad phenotypic variability, ranging from mild bruising to severe hemorrhages. Diagnosis involves specialized analyses such as platelet aggregation and genetic studies, necessitating a multidisciplinary approach for management [2]. Our case report describes a child with recurrent epistaxis, initially diagnosed with immune thrombocytopenia. Subsequent presentations led to suspicion of von Willebrand disease, but further examinations revealed a platelet function disorder. Genetic testing confirmed mutations associated with SPD. Treatment options include desmopressin, antifibrinolytic agents, and platelet transfusions, tailored to individual needs. The discussion underscores the diverse manifestations of SPD, emphasizing the importance of thorough diagnostic assessments. Treatment strategies aim to alleviate bleeding symptoms and mitigate associated risks, with a strong focus on personalized care. Challenges in managing SPD include missed diagnoses and the influence of genetic variations on disease severity. Ultimately, early detection and individualized therapies are essential for effectively managing SPD, underscoring the ongoing need for research to enhance outcomes for affected individuals.","PeriodicalId":91713,"journal":{"name":"International journal of pediatrics and child health","volume":"226 22","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-05-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International journal of pediatrics and child health","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.12974/2311-8687.2024.12.05","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Inherited platelet disorders, including platelet storage pool diseases (SPDs), manifest in various bleeding symptoms, with severity often categorized based on their effects on either the surface receptors or internal structures of platelets [1]. This rare condition, characterized by defects in platelet granules, exhibits broad phenotypic variability, ranging from mild bruising to severe hemorrhages. Diagnosis involves specialized analyses such as platelet aggregation and genetic studies, necessitating a multidisciplinary approach for management [2]. Our case report describes a child with recurrent epistaxis, initially diagnosed with immune thrombocytopenia. Subsequent presentations led to suspicion of von Willebrand disease, but further examinations revealed a platelet function disorder. Genetic testing confirmed mutations associated with SPD. Treatment options include desmopressin, antifibrinolytic agents, and platelet transfusions, tailored to individual needs. The discussion underscores the diverse manifestations of SPD, emphasizing the importance of thorough diagnostic assessments. Treatment strategies aim to alleviate bleeding symptoms and mitigate associated risks, with a strong focus on personalized care. Challenges in managing SPD include missed diagnoses and the influence of genetic variations on disease severity. Ultimately, early detection and individualized therapies are essential for effectively managing SPD, underscoring the ongoing need for research to enhance outcomes for affected individuals.
遗传性血小板疾病,包括血小板储存库疾病(SPDs),表现为各种出血症状,其严重程度通常根据其对血小板表面受体或内部结构的影响进行分类[1]。这种以血小板颗粒缺陷为特征的罕见疾病表现出广泛的表型差异,从轻微瘀伤到严重出血不等。诊断需要进行专门的分析,如血小板聚集和基因研究,因此必须采用多学科方法进行管理 [2]。我们的病例报告描述了一名反复鼻衄的患儿,最初诊断为免疫性血小板减少症。随后的症状让人怀疑是冯-威廉氏病,但进一步检查发现是血小板功能紊乱。基因检测证实了与 SPD 相关的突变。治疗方案包括去氨加压素、抗纤维蛋白溶解剂和血小板输注,并根据个人需求量身定制。讨论强调了 SPD 的多种表现形式,强调了全面诊断评估的重要性。治疗策略旨在减轻出血症状并降低相关风险,重点关注个性化护理。管理 SPD 所面临的挑战包括漏诊和基因变异对疾病严重程度的影响。归根结底,早期检测和个体化治疗对于有效控制 SPD 至关重要,这也强调了为提高患者的治疗效果而持续开展研究的必要性。